Peetz Christopher

Average Profitability
41.16%
Insider Buys Quantity
4
Insider Buys Sum
$588,435.75
Insider Sells Quantity
5
Insider Sells Sum
$692,336.08

Insider Activity of Peetz Christopher

According to the SEC Form 4 filings, Peetz Christopher, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11222 shares for $303,525,
    over all time since 2019-09-06, has bought 42140 shares for $588,436, and sold 29223 shares for $692,336.

The largest purchase of all time was on 2021-11-24 and amounted to 14000 shares of Mirum Pharmaceuticals, Inc. for $201,600.

The largest sale of all time was on 2024-02-02 and amounted to 6013 shares of Mirum Pharmaceuticals, Inc. for $157,491.

Biography of Peetz Christopher

No biography is available at this moment.

2024-02-02SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF EXECUTIVE OFFICER
6,013
0.0127%
$26.19$157,491+9.28%
2024-01-08SaleMirum Pharmaceuticals, Inc.
MIRM
PRESIDENT AND CEO
5,209
0.011%
$28.03$146,033-0.81%
2023-07-03SaleMirum Pharmaceuticals, Inc.
MIRM
President and CEO
5,498
0.0146%
$25.65$141,005+5.32%
2023-01-09SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF EXECUTIVE OFFICER
5,159
0.0141%
$20.62$106,390
2021-11-24PurchaseMirum Pharmaceuticals, Inc.
MIRM
President and CEO
14,000
0.0464%
$14.40$201,600+56.49%
2021-10-01SaleMirum Pharmaceuticals, Inc.
MIRM
President and CEO
7,344
0.0241%
$19.26$141,416+13.33%
2020-12-23PurchaseMirum Pharmaceuticals, Inc.
MIRM
President and CEO
10,000
0.0385%
$18.70$186,960-5.94%
2019-09-09PurchaseMirum Pharmaceuticals, Inc.
MIRM
President and CEO
8,640
0.0517%
$11.14$96,264+61.03%
2019-09-06PurchaseMirum Pharmaceuticals, Inc.
MIRM
President and CEO
9,500
0.0531%
$10.91$103,612+53.04%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.